Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Reduction of active disease by preventive therapy has the potential to make an important contribution towards the goal of tuberculosis (TB) elimination. This report summarises discussions amongst a Working Group convened to consider areas of research that will be important in optimising the design and delivery of preventative therapies. The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB.

Original publication




Journal article


Tuberculosis (Edinb)

Publication Date





447 - 452


Antitubercular Agents, Bacterial Load, Biomarkers, Drug Design, Female, Humans, Immunization Programs, Latent Tuberculosis, Male, Models, Animal, Mycobacterium tuberculosis, South Africa, Tuberculosis, Tuberculosis Vaccines